Loading...
Thumbnail Image
Publication

Selective chr21 homolog silencing reveals polymorphisms influence the epigenetic silencing and functional dosage of RWDD2B [preprint]

Larsen, Eric C
Moon, Jennifer E
King, Oliver D
Lawrence, Jeanne B
Citations
Google Scholar:
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Preprint
Publication Date
2025-09-18
Subject Area
Embargo Expiration Date
Abstract

Polymorphisms that affect chr21 gene expression have significance for both variable severity in Down syndrome and common multifactorial conditions. Results here demonstrate "selective homolog silencing" in cells from even one individual can provide a valuable complement to large studies. In trisomic iPSC subclones that silence different chr21 homologs (via -based silencing), we discovered unusually large, homolog-specific, differences in in iPSCs, cortical organoids and endothelial cells. RNA FISH showed transcription almost entirely from the H1 homolog, correlated with CpG promoter methylation differences. Polymorphisms different on H1 versus H2/H3 had strongest eQTLs in GTEx, especially in brain. Collective results indicate RWDD2B functional dosage is more frequently disconnected from copy number even compared to neighboring genes. RWDD2B function is unknown, but nearby methyl-eQTLs are implicated in osteoarthritis, and potential roles in inflammation or immune response merit consideration. This study has significance for RWDD2B regulation and demonstrates a cell-based methodology to study polymorphisms.

Source

Larsen EC, Moon JE, King OD, Lawrence JB. Selective chr21 homolog silencing reveals polymorphisms influence the epigenetic silencing and functional dosage of RWDD2B. bioRxiv [Preprint]. 2025 Sep 18:2025.09.17.676855. doi: 10.1101/2025.09.17.676855. PMID: 41000861; PMCID: PMC12458407.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/2025.09.17.676855
PubMed ID
41000861
Other Identifiers
Notes

This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.

Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.